Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Fluoroquinolone; topoisomerase IV and bacterial...
Fluoroquinolone; topoisomerase IV and bacterial...
Mycotoxin.
STING agonist
Prolyl hydroxylase inhibitor.
Isoquinoline alkaloid found in Corydalis; 5-HT1...
Neuropeptide found in crustaceans and insects.<...
Macrolide; peptidyl transferase inhibitor, prot...
Endogenous peptide, involved in stress signalin...
Induces activation of Nrf2; inhibits apoptosis ...
CRM1-selective inhibitor of nuclear export.
Iridoid glycoside found in Gardenia.
ACE inhibitor.
Synthetic peptide, vasopressin analog; AVPR1 ag...
Imidazoline derivative; α1-adrenergic agonist,...
Promotes degradation of cIAP1
ROCK inhibitor.
Endogenous peptide neurotransmitter, involved i...
Expectorant.
Statin; HMG-CoA reductase inhibitor, potential ...